Please assess the completion status of the following clinical trial:

Trial Title: Radio Frequency (RF) Device for Reduction in Size of Localized Areas of the Body

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Female or Male~* Minimum age of 18 years~* Non-smoking for at least 3 months and willing to refrain from smoking for the duration of the study.~* Post-menopausal, or on birth control with no plans to become pregnant for the duration of the study (female only)~* Minimum Body Mass Index of 20~* Visible fat in the area to be treated Area to be treated to measure at least 20.0mm in vertical fold, as measured with industry standard fat caliper~* Subject must be able to read, understand and sign the Consent Form~* Subject must adhere to the follow-up schedule and study instructions~* Subject must adhere to the same diet and/or exercise routine throughout the study, and agree to maintain the same weight throughout the study (within 6 lbs of initial weight)~Exclusion Criteria:~* Significant weight fluctuation (+/-10 lbs) in the past 6 months~* Taking weight-loss medications/supplements~* Participation in any other clinical study~* Cellulite treatment within 3 months of the treatment~* Surgical or non-surgical treatments to the target area in the last 12 months, e.g., liposuction~* Prior treatment to the target area within the last 12 months~* Arteriosclerosis or weakened blood vessels~* Heart disease~* Thromboembolic disease~* Diagnosed or documented immune system disorders~* Bleeding disorders.~* Presence of uncontrolled hypertension~* Taking prescription anticoagulants~* History of keloid formation~* Malignant tumors in the target area~* Diabetes~* Any disease or condition that could impair wound healing~* Skin abnormalities in the target area, e.g., cuts, scrapes, wounds, scars, large moles~* Infection in the target area~* Implanted electrical device(s)~* Pregnant or lactating

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: f

Study Arms:
- RF treatment (Type: EXPERIMENTAL): Abdomen, flank or thigh treated with RF device

Based on this trial design, predict the completion outcome and termination type (if applicable).